Camille Gérard
0000-0002-6007-1746
The Francis Crick Institute
2 papers found
Refreshing results…
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
Estimated Costs of the Ipilimumab–Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma
Missing publications? Search for publications with a matching author name.